Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

January 2025

Leica Biosystems And Indica Labs Announce Significant Strategic Investment And Creation Of Digital Pathology Platform

2025-01-08T14:17:11+00:00

Leica Biosystems, a global leader in anatomic and digital pathology solutions; and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.

Leica Biosystems And Indica Labs Announce Significant Strategic Investment And Creation Of Digital Pathology Platform2025-01-08T14:17:11+00:00

Introducing Educate by Medica: Redefining Healthcare Learning

2025-01-08T12:10:29+00:00

Medica is pleased to announce that JCA Seminars has rebranded to Educate by Medica. This marks an exciting new chapter as Medica continues to evolve and strengthen its commitment to supporting professional development within the healthcare community.

Introducing Educate by Medica: Redefining Healthcare Learning2025-01-08T12:10:29+00:00

Deciphex Secures $32.3M Series C to Address Global Pathology Shortage

2025-01-08T09:36:40+00:00

Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten Ventures with significant participation from ACT Venture Capital, Seroba, Charles River Laboratories (NYSE: CRL), IRRUS Investments, HBAN Medtech Syndicate and Nextsteps Capital, the funding will advance Deciphex's mission to democratize access to high-quality pathology through a technology-enabled global network of pathologists.

Deciphex Secures $32.3M Series C to Address Global Pathology Shortage2025-01-08T09:36:40+00:00

Enhancing Interpretability: A Novel Approach for Accurate Breast Cancer Diagnosis in Digital Pathology

2025-06-26T15:59:44+00:00

Although AI models have demonstrated immense potential for analyzing complex data, their ‘black box’ nature often raises concerns, particularly when AI tools are used for cancer diagnosis and clinical decision making. However, a recent study conducted by researchers at Urmia University and Carleton University may have found a solution that bridges the gap between the analytical capabilities and the limited interpretability of AI tools.

Enhancing Interpretability: A Novel Approach for Accurate Breast Cancer Diagnosis in Digital Pathology2025-06-26T15:59:44+00:00

Case of the Month | January 2025 | Cytologic-Histologic Correlation in Uncommon Neoplasms

2025-07-28T21:55:24+00:00

A 10-year-old intact male Staffordshire Bull Terrier was presented to the veterinary clinic with a history of an enlarged popliteal lymph node on the right hind limb. A fine-needle aspiration (FNA) was performed, and the sample was submitted to NationWide Laboratories in the UK for evaluation.

Case of the Month | January 2025 | Cytologic-Histologic Correlation in Uncommon Neoplasms2025-07-28T21:55:24+00:00

December 2024

What’s Missing from Digital Pathology: Spatial Transcriptomics, Multi-omics, and More – Margaret Flanagan

2024-12-20T17:23:09+00:00

In this episode of PathPulse: Pathology Innovators in Action, we were thrilled to welcome neuropathologist Margaret Flanagan, MD, talk with us about what is missing from digital pathology, highlighting spatial transcriptomics, multi-omics, and more.

What’s Missing from Digital Pathology: Spatial Transcriptomics, Multi-omics, and More – Margaret Flanagan2024-12-20T17:23:09+00:00

Molecular Pathology Laboratory Network, Inc. Selects HALO AP® to Deliver Comprehensive Reference Laboratory Services and Biopharma Laboratory Support

2024-12-20T14:39:28+00:00

Indica Labs announced today that Molecular Pathology Laboratory Network, Inc. (MPLN), a leader in laboratory medicine, hematopathology, and solid tumor oncology testing, has selected the HALO AP® platform from Indica Labs to deliver digital pathology services to both clinical reference labs and biopharma clients. HALO AP® is now in the final stages of clinical validation in MPLN’s CAP/CLIA-certified laboratory, where it is being prepared for initial deployment as a laboratory developed test (LDT) in the setting of urothelial bladder cancer and myeloid neoplasms. Additional disease indications will be validated in HALO AP® as LDTs in a stepwise manner once the initial indications are fully deployed.

Molecular Pathology Laboratory Network, Inc. Selects HALO AP® to Deliver Comprehensive Reference Laboratory Services and Biopharma Laboratory Support2024-12-20T14:39:28+00:00

Source LDPath Announces UKAS 15189:2022 Accreditation

2024-12-20T10:03:22+00:00

Source LDPath, a division of Source BioScience, has been accredited by UKAS to ISO 15189:2022 standards at its Chichester site (UKAS no. 9571). This complements the earlier accreditation secured by its Nottingham laboratory, demonstrating the organisation's commitment to high standards in clinical laboratory quality and competence.

Source LDPath Announces UKAS 15189:2022 Accreditation2024-12-20T10:03:22+00:00
Go to Top